MeiraGTx (MGTX) Competitors $8.41 -0.04 (-0.47%) Closing price 04:00 PM EasternExtended Trading$8.42 +0.01 (+0.12%) As of 04:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MGTX vs. ALVO, IBRX, BHC, CPRX, TARS, IDYA, BEAM, CDTX, IRON, and AGIOShould you be buying MeiraGTx stock or one of its competitors? The main competitors of MeiraGTx include Alvotech (ALVO), ImmunityBio (IBRX), Bausch Health Cos (BHC), Catalyst Pharmaceuticals (CPRX), Tarsus Pharmaceuticals (TARS), IDEAYA Biosciences (IDYA), Beam Therapeutics (BEAM), Cidara Therapeutics (CDTX), Disc Medicine (IRON), and Agios Pharmaceuticals (AGIO). These companies are all part of the "pharmaceutical products" industry. MeiraGTx vs. Its Competitors Alvotech ImmunityBio Bausch Health Cos Catalyst Pharmaceuticals Tarsus Pharmaceuticals IDEAYA Biosciences Beam Therapeutics Cidara Therapeutics Disc Medicine Agios Pharmaceuticals Alvotech (NASDAQ:ALVO) and MeiraGTx (NASDAQ:MGTX) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, institutional ownership, risk, earnings, analyst recommendations, dividends, media sentiment and profitability. Which has better earnings & valuation, ALVO or MGTX? MeiraGTx has lower revenue, but higher earnings than Alvotech. MeiraGTx is trading at a lower price-to-earnings ratio than Alvotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlvotech$491.98M5.26-$231.86M$0.2337.30MeiraGTx$33.28M20.33-$147.79M-$2.04-4.12 Do analysts prefer ALVO or MGTX? Alvotech currently has a consensus price target of $14.00, suggesting a potential upside of 63.17%. MeiraGTx has a consensus price target of $24.00, suggesting a potential upside of 185.37%. Given MeiraGTx's stronger consensus rating and higher probable upside, analysts plainly believe MeiraGTx is more favorable than Alvotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alvotech 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25MeiraGTx 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Do insiders & institutionals have more ownership in ALVO or MGTX? 67.5% of MeiraGTx shares are held by institutional investors. 7.5% of MeiraGTx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, ALVO or MGTX? Alvotech has a beta of 0.1, indicating that its stock price is 90% less volatile than the S&P 500. Comparatively, MeiraGTx has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Does the media favor ALVO or MGTX? In the previous week, Alvotech had 7 more articles in the media than MeiraGTx. MarketBeat recorded 7 mentions for Alvotech and 0 mentions for MeiraGTx. Alvotech's average media sentiment score of 0.85 beat MeiraGTx's score of 0.00 indicating that Alvotech is being referred to more favorably in the media. Company Overall Sentiment Alvotech Positive MeiraGTx Neutral Is ALVO or MGTX more profitable? Alvotech has a net margin of 11.26% compared to MeiraGTx's net margin of -415.39%. Alvotech's return on equity of -38.36% beat MeiraGTx's return on equity.Company Net Margins Return on Equity Return on Assets Alvotech11.26% -38.36% 9.28% MeiraGTx -415.39%-314.44%-63.28% SummaryAlvotech beats MeiraGTx on 8 of the 15 factors compared between the two stocks. Get MeiraGTx News Delivered to You Automatically Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGTX vs. The Competition Export to ExcelMetricMeiraGTxMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$679.78M$3.36B$6.16B$10.57BDividend YieldN/A2.28%5.66%4.69%P/E Ratio-4.1222.0285.5827.12Price / Sales20.33463.22612.62135.31Price / CashN/A46.3226.3031.10Price / Book9.679.9612.876.67Net Income-$147.79M-$52.42M$3.30B$276.23M7 Day Performance1.94%5.95%4.80%3.31%1 Month Performance9.36%11.59%8.11%10.76%1 Year Performance102.65%25.01%75.85%33.58% MeiraGTx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGTXMeiraGTx3.9313 of 5 stars$8.41-0.5%$24.00+185.4%+103.6%$679.78M$33.28M-4.12300ALVOAlvotech3.9937 of 5 stars$8.40+0.7%$14.00+66.7%-32.4%$2.51B$560.10M36.521,032IBRXImmunityBio2.6952 of 5 stars$2.57+1.2%$10.75+318.3%-25.9%$2.40B$14.74M-5.35590BHCBausch Health Cos4.7204 of 5 stars$6.47-0.2%$9.00+39.1%-19.7%$2.40B$9.63B24.8920,700CPRXCatalyst Pharmaceuticals4.8594 of 5 stars$19.55+0.2%$33.20+69.8%+4.2%$2.39B$491.73M11.8580Analyst DowngradeBuyback AnnouncementTARSTarsus Pharmaceuticals0.6834 of 5 stars$58.08+3.2%$66.67+14.8%+92.3%$2.38B$182.95M-24.9350Gap UpIDYAIDEAYA Biosciences4.1875 of 5 stars$27.19+1.3%$43.36+59.5%-7.8%$2.35B$7M-7.1780Analyst UpgradeBEAMBeam Therapeutics2.8984 of 5 stars$23.91+4.1%$46.40+94.1%+10.0%$2.32B$63.52M-5.31510CDTXCidara Therapeutics4.1333 of 5 stars$95.26+5.3%$119.43+25.4%+835.7%$2.29B$1.27M-8.5690Analyst ForecastHigh Trading VolumeIRONDisc Medicine2.4262 of 5 stars$65.06-0.7%$98.30+51.1%+35.8%$2.28BN/A-14.5530AGIOAgios Pharmaceuticals4.4261 of 5 stars$39.27+0.9%$56.00+42.6%-2.0%$2.26B$36.50M3.57390 Related Companies and Tools Related Companies ALVO Competitors IBRX Competitors BHC Competitors CPRX Competitors TARS Competitors IDYA Competitors BEAM Competitors CDTX Competitors IRON Competitors AGIO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MGTX) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MeiraGTx Holdings PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share MeiraGTx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
